Northern Trust
YMAB

Northern Trust’s Y-mAbs Therapeutics YMAB Stock Holding History

Northern Trust’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-308,130
Closed -$1.39M – 4551
2025
Q2 		$1.39M Sell
308,130
-19,771
-6% -$88.9K ﹤0.01% 3206
2025
Q1 		$1.45M Sell
327,901
-31,322
-9% -$182K ﹤0.01% 3097
2024
Q4 		$2.81M Buy
359,223
+21,936
+7% +$267K ﹤0.01% 2828
2024
Q3 		$4.44M Buy
337,287
+19,482
+6% +$247K ﹤0.01% 2559
2024
Q2 		$3.84M Sell
317,805
-3,910
-1% -$52.8K ﹤0.01% 2538
2024
Q1 		$5.23M Sell
321,715
-3,724
-1% -$50.2K ﹤0.01% 2422
2023
Q4 		$2.22M Buy
325,439
+2,252
+0.7% +$13K ﹤0.01% 2943
2023
Q3 		$1.76M Sell
323,187
-5,335
-2% -$31.1K ﹤0.01% 3012
2023
Q2 		$2.23M Buy
328,522
+26,193
+9% +$196K ﹤0.01% 2949
2023
Q1 		$1.51M Sell
302,329
-18,082
-6% -$73.8K ﹤0.01% 3062
2022
Q4 		$1.56M Sell
320,411
-8,612
-3% -$62.6K ﹤0.01% 3113
2022
Q3 		$4.75M Sell
329,023
-4,075
-1% -$67.5K ﹤0.01% 2520
2022
Q2 		$5.04M Buy
333,098
+5,845
+2% +$68.2K ﹤0.01% 2506
2022
Q1 		$3.89M Sell
327,253
-16,734
-5% -$172K ﹤0.01% 2734
2021
Q4 		$5.58M Sell
343,987
-3,047
-0.9% -$65.1K ﹤0.01% 2621
2021
Q3 		$9.9M Buy
347,034
+628
+0.2% +$19.8K ﹤0.01% 2272
2021
Q2 		$11.7M Buy
346,406
+605
+0.2% +$19.4K ﹤0.01% 2259
2021
Q1 		$10.5M Sell
345,801
-7,298
-2% -$299K ﹤0.01% 2260
2020
Q4 		$17.5M Sell
353,099
-21,097
-6% -$976K ﹤0.01% 1882
2020
Q3 		$14.4M Sell
374,196
-5,060
-1% -$201K ﹤0.01% 1868
2020
Q2 		$16.4M Buy
379,256
+82,770
+28% +$3.13M ﹤0.01% 1775
2020
Q1 		$7.74M Buy
296,486
+7,588
+3% +$220K ﹤0.01% 2043
2019
Q4 		$9.03M Buy
288,898
+41,572
+17% +$1.23M ﹤0.01% 2239
2019
Q3 		$6.45M Buy
247,326
+133,303
+117% +$3.41M ﹤0.01% 2401
2019
Q2 		$2.61M Buy
114,023
+32,531
+40% +$747K ﹤0.01% 2923
2019
Q1 		$2.14M Buy
81,492
+6,163
+8% +$135K ﹤0.01% 3047
2018
Q4 		$1.53M Buy
+75,329
New +$1.73M ﹤0.01% 3190

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northern Trust's YMAB Position: Q3 2025 in Review

Northern Trust sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 308,130 shares — an estimated $1.39M sold.

Northern Trust first reported a position in YMAB in Q4 2018 and held it in 27 quarters. The position peaked at $17.5M in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • Northern Trust reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Northern Trust sold 308,130 Y-mAbs Therapeutics shares in Q3 2025, an estimated $1.39M.
  • Northern Trust first reported a position in Y-mAbs Therapeutics in Q4 2018 and held it in 27 quarters.
  • Northern Trust's Y-mAbs Therapeutics position peaked at $17.5M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.